BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26296722)

  • 21. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
    Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
    Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular calcification and bone mineral density in recurrent kidney stone formers.
    Shavit L; Girfoglio D; Vijay V; Goldsmith D; Ferraro PM; Moochhala SH; Unwin R
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):278-85. PubMed ID: 25635036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heritability of dietary traits that contribute to nephrolithiasis in a cohort of adult sibships.
    Lieske JC; Turner ST; Edeh SN; Ware EB; Kardia SL; Smith JA
    J Nephrol; 2016 Feb; 29(1):45-51. PubMed ID: 25963767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for nephrolithiasis in children.
    Acar B; Inci Arikan F; Emeksiz S; Dallar Y
    World J Urol; 2008 Dec; 26(6):627-30. PubMed ID: 18810456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of the body mass index and calcium nephrolithiasis in adult population.
    Milicevic S; Bijelic R; Krivokuca V; Bojic M; Popovic-Pejicic S; Bojanic N
    Med Arch; 2013 Dec; 67(6):423-7. PubMed ID: 25568513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ureteral stone location at emergency room presentation with colic.
    Eisner BH; Reese A; Sheth S; Stoller ML
    J Urol; 2009 Jul; 182(1):165-8. PubMed ID: 19450856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metaphylaxis of nephrolithiasis.
    Jacobellis U
    Urol Int; 2007; 79 Suppl 1():51-5. PubMed ID: 17726353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining hypercalciuria in nephrolithiasis.
    Pak CY; Sakhaee K; Moe OW; Poindexter J; Adams-Huet B; Pearle MS; Zerwekh JE; Preminger GM; Wills MR; Breslau NA; Bartter FC; Brater DC; Heller HJ; Odvina CV; Wabner CL; Fordtran JS; Oh M; Garg A; Harvey JA; Alpern RJ; Snyder WH; Peters PC
    Kidney Int; 2011 Oct; 80(7):777-82. PubMed ID: 21775970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial calcium stone disease: TaqI polymorphism and the vitamin D receptor.
    Jackman SV; Kibel AS; Ovuworie CA; Moore RG; Kavoussi LR; Jarrett TW
    J Endourol; 1999 May; 13(4):313-6. PubMed ID: 10405913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors Associated With the Lower Prevalence of Nephrolithiasis in Children Compared With Adults.
    Grases F; Rodriguez A; Costa-Bauza A; Saez-Torres C; Rodrigo D; Gómez C; Mir-Perello C; Frontera G
    Urology; 2015 Sep; 86(3):587-92. PubMed ID: 26144339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis and treatment of nephrolithiasis. What is established?].
    Pfau A; Eckardt KU; Knauf F
    Internist (Berl); 2015 Dec; 56(12):1361-8. PubMed ID: 26530696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass.
    Ferraro PM; Minucci A; Primiano A; De Paolis E; Gervasoni J; Persichilli S; Naticchia A; Capoluongo E; Gambaro G
    Urolithiasis; 2017 Jun; 45(3):291-294. PubMed ID: 27639704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective study of nephrolithiasis occurrence in children receiving cefotriaxone.
    Youssef DM; Sherief LM; Sherbiny HS; ElAttar MY; Sheikh AR; Fawzy FM; Adham T
    Nephrology (Carlton); 2016 May; 21(5):432-7. PubMed ID: 26369807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Essential arterial hypertension and stone disease.
    Borghi L; Meschi T; Guerra A; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis.
    Dinour D; Beckerman P; Ganon L; Tordjman K; Eisenstein Z; Holtzman EJ
    J Urol; 2013 Aug; 190(2):552-7. PubMed ID: 23470222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of vitamin D deficiency in calcium stone-forming patients.
    Girón-Prieto MS; Del Carmen Cano-García M; Arrabal-Polo MÁ; Poyatos-Andujar A; Quesada-Charneco M; de Haro-Muñoz T; Arias-Santiago S; Arrabal-Martín M
    Int Urol Nephrol; 2016 Aug; 48(8):1243-1246. PubMed ID: 27093967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical observations on 2086 patients with upper urinary tract stone.
    Trinchieri A; Rovera F; Nespoli R; Currò A
    Arch Ital Urol Androl; 1996 Sep; 68(4):251-62. PubMed ID: 8936717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study.
    Borghi L; Meschi T; Amato F; Briganti A; Novarini A; Giannini A
    J Urol; 1996 Mar; 155(3):839-43. PubMed ID: 8583588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.